Sawyer & Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
22,195
-1
-0% -$81 0.58% 53
2026
Q1
$1.92M Sell
22,196
-188
-0.8% -$18K 0.74% 45
2025
Q4
$2.15M Buy
22,384
+969
+5% +$94.1K 0.76% 45
2025
Q3
$1.87M Sell
21,415
-780
-4% -$71.7K 0.71% 50
2025
Q2
$1.74M Buy
22,195
+2,004
+10% +$170K 0.58% 53
2025
Q1
$1.81M Sell
20,191
-572
-3% -$51.2K 0.73% 51
2024
Q4
$1.66M Sell
20,763
-680
-3% -$58.9K 0.61% 52
2024
Q3
$1.93M Buy
21,443
+92
+0.4% +$7.74K 0.71% 50
2024
Q2
$1.68M Sell
21,351
-255
-1% -$20.9K 0.67% 52
2024
Q1
$1.88M Buy
21,606
+17
+0.1% +$1.45K 0.75% 48
2023
Q4
$1.78M Sell
21,589
-684
-3% -$52.1K 0.78% 47
2023
Q3
$1.75M Sell
22,273
-90
-0.4% -$7.53K 0.81% 45
2023
Q2
$1.97M Hold
22,363
0.9% 43
2023
Q1
$1.79M Sell
22,363
-208
-0.9% -$17K 0.97% 43
2022
Q4
$1.75M Buy
22,571
+31
+0.1% +$2.51K 0.86% 44
2022
Q3
$1.82M Hold
22,540
0.99% 39
2022
Q2
$2.02M Hold
22,540
1.03% 36
2022
Q1
$2.5M Sell
22,540
-17
-0.1% -$1.8K 1.12% 34
2021
Q4
$2.33M Sell
22,557
-84
-0.4% -$9.73K 1.01% 38
2021
Q3
$2.84M Hold
22,641
1.34% 25
2021
Q2
$2.81M Sell
22,641
-85
-0.4% -$10.7K 1.31% 26
2021
Q1
$2.69M Sell
22,726
-330
-1% -$38.7K 1.34% 25
2020
Q4
$2.7M Hold
23,056
1.38% 24
2020
Q3
$2.4M Sell
23,056
-267
-1% -$26.8K 1.43% 23
2020
Q2
$2.14M Sell
23,323
-15
-0.1% -$1.44K 1.32% 24
2020
Q1
$2.1M Buy
23,338
+25
+0.1% +$2.66K 1.68% 15
2019
Q4
$2.65M Buy
23,313
+569
+3% +$62.4K 1.7% 15
2019
Q3
$2.47M Sell
22,744
-420
-2% -$43.8K 1.76% 14
2019
Q2
$2.26M Sell
23,164
-650
-3% -$59.3K 1.51% 17
2019
Q1
$2.17M Hold
23,814
1.42% 20
2018
Q4
$2.17M Sell
23,814
-150
-0.6% -$14K 1.59% 17
2018
Q3
$2.36M Buy
23,964
+85
+0.4% +$7.86K 1.44% 19
2018
Q2
$2.04M Buy
23,879
+1,515
+7% +$127K 1.34% 20
2018
Q1
$1.79M Sell
22,364
-310
-1% -$25.6K 1.21% 25
2017
Q4
$1.83M Buy
+22,674
New +$1.82M 1.2% 26

Other funds holding MDT

Sawyer & Company's MDT Position: Q2 2026 in Review

Sawyer & Company reduced its Medtronic (MDT) stake by 0% in Q2 2026, selling an estimated $81 and leaving 22,195 shares worth $1.74M. The position accounts for 0.58% of the portfolio, ranked #53.

Sawyer & Company first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.84M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Sawyer & Company held 22,195 shares of Medtronic worth $1.74M as of Q2 2026.
  • Sawyer & Company sold 1 Medtronic share in Q2 2026, an estimated $81.
  • Medtronic made up 0.58% of Sawyer & Company's portfolio in Q2 2026, its #53 holding.
  • Sawyer & Company first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
  • Sawyer & Company's Medtronic position peaked at $2.84M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.